Teriparatide (Bone Medical)

特立帕肽(Bone Medical)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameTeriparatide (Bone Medical)
Drug Alias NamePTH - Bone MedicalPerthoxalCaPTHymoneBN-003
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormone
Mechanisms of ActionParathyroid hormone replacements
TargetsParathyroid hormone receptor
Therapy Area/IndicationsOsteoporosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBotanix Pharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBotanix Pharmaceuticals Ltd
Active IndicationsN/A
Inactive IndicationsOsteoporosis

Other Information

ATC CodeN/A